Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4321654)

Published in Onco Targets Ther on January 30, 2015

Authors

Sinh Truong Nguyen1, Huyen Lam Nguyen1, Viet Quoc Pham1, Giang Thuy Nguyen1, Cuong Do-Thanh Tran1, Ngoc Kim Phan2, Phuc Van Pham2

Author Affiliations

1: Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University, Ho Chi Minh City, Vietnam.
2: Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University, Ho Chi Minh City, Vietnam ; Faculty of Biology, University of Science, Vietnam National University, Ho Chi Minh City, Vietnam.

Associated clinical trials:

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma | NCT00846456

Articles cited by this

Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17

Dendritic cells and the control of immunity. Nature (1998) 56.54

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med (1994) 21.52

Tumour stem cells and drug resistance. Nat Rev Cancer (2005) 15.21

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (1995) 5.13

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol (1999) 4.53

Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol (2007) 3.93

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One (2008) 3.36

ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics (2008) 3.35

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res (2009) 3.28

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One (2008) 2.90

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44

Cancer stem cells and self-renewal. Clin Cancer Res (2010) 2.37

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32

Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med (2013) 2.20

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst (2010) 1.89

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int (2005) 1.83

Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis (2010) 1.70

Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther (2011) 1.70

Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch (2006) 1.58

Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond) (2012) 1.54

Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev (2008) 1.32

Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. World J Gastroenterol (2008) 1.19

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy. J Transl Med (2011) 1.17

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother (2002) 1.13

Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1. Cancer Res (2004) 1.10

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol Immunother (2002) 1.08

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunol Immunother (2013) 1.08

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro. J Immunol (2005) 1.00

Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells. Onco Targets Ther (2011) 1.00

Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol Immunother (1999) 0.99

Generation of dendritic cells from rabbit bone marrow mononuclear cell cultures supplemented with hGM-CSF and hIL-4. Vet Immunol Immunopathol (2005) 0.98

Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. BMC Cancer (2014) 0.94

Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells. J Exp Med (2001) 0.93

Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo. Int J Cancer (2003) 0.92

Survival probability and prognostic factors for breast cancer patients in Vietnam. Glob Health Action (2013) 0.91

Isolation and propagation of colon cancer stem cells. Methods Mol Biol (2013) 0.89

Brain stem cells as the cell of origin in glioma. World J Stem Cells (2014) 0.88

IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J Leukoc Biol (2004) 0.86

Tocotrienol-adjuvanted dendritic cells inhibit tumor growth and metastasis: a murine model of breast cancer. PLoS One (2013) 0.83

Comparing the ability of freshly generated and cryopreserved dendritic cell vaccines to inhibit growth of breast cancer in a mouse model. Biores Open Access (2012) 0.83

Targeting cancer stem cells via dendritic-cell vaccination. Oncoimmunology (2012) 0.82

Isolation of human melanoma stem cells using ALDH as a marker. Curr Protoc Stem Cell Biol (2013) 0.81

Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine. Vaccine (2011) 0.81

A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells. Int Immunol (2003) 0.81

Effect of verapamil on cell cycle transit and c-myc gene expression in normal and malignant murine cells. Br J Cancer (1989) 0.78

Dendritic cells: potential role in cancer therapy. Cytotechnology (1997) 0.78

Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer. Surgery (1997) 0.77

Vaccine studies demonstrate promise of immunotherapy to treat breast cancer and prevent recurrence. Oncology (Williston Park) (2000) 0.76

Articles by these authors

A simple in vitro method for evaluating dendritic cell-based vaccinations. Onco Targets Ther (2014) 0.78